|
Protocol Number:
97-C-0147
- Title:
Collection of Serum and Tissue Samples from Patients with Biopsy-Proved or Suspected Malignant Disease
- Number:
97-C-0147
- Summary:
Selected patients suspected of having or with prior biopsy proof of malignant disease will be seen in the Urologic Oncology Branch, NCI. Blood samples may be collected at the time of the initial visit and at periodic intervals during the course of the disease. These samples will be stored in the tissue bank of the Urologic Oncology Branch. Aliquots of malignant and normal tissue will be collected at the time of surgery and stored in the tissue bank, Urologic Oncology Branch, NCI. These materials will be used in the research efforts of the Urologic Oncology Branch, NCI.
- Sponsoring Institute:
-
National Cancer Institute (NCI)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
Patients suspected of having, or with biopsy proof of malignant disease are eligible.
Patients must be able to provide informed consent.
- Special Instructions:
Currently Not Provided
- Keywords:
-
Tissue Procurement
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Neoplasm
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- National Cancer Institute
- Contact(s):
-
NCI Referral Office
National Institute of Health Clinical Center (CC), 9000 Rockville Pike, Bethesda, Maryland 20892, United States: NCI Clinical Trials Referral Office Phone: 1-888-NCI-1937 Fax: Not Listed Electronic Address: ncicssc@mail.nih.gov
- Citation(s):
-
Assessment of growth-limiting events caused by 5-fluorouracil in mouse cells in human cells
-
Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro
-
Novel mechanisms of resistance to 5-fluorouacil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/13/2009
|
|